secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2022-10-20T23:59:59+00:00
Accession:  0001022079-22-000136
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics reports Q3 EPS $2.17, adjusted $2.36; raises 2022 guidance on base business growth of 5.1%
--------------------------------------------------------------------------------

- Q3 2022 net revenues $2.49B, down 10.4% YoY; base business revenues $2.17B, up 5.1% YoY; COVID-19 testing $316M, down 55.4%.
- Reported diluted EPS $2.17 (down 46.0%); adjusted diluted EPS $2.36 (down 40.4%).
- Full-year 2022 guidance raised: net revenues $9.72B-$9.86B; adjusted EPS $9.75-$9.95 (prior $9.55-$9.95).
- CEO transition: Jim Davis becomes CEO and President on Nov 1; Steve Rusckowski becomes Executive Chairman through March 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000136/0001022079-22-000136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000136/dgx-20221020.htm
  HTML page:      https://secwatch.observer/filing/0001022079-22-000136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer